Personalized Medicine Market By Application(Health Informatics, Clinical Research, Companion Diagnostics, Biomarker Identification), By End-user(Hospitals, Contract Research Organizations, Molecular Diagnostic Laboratories and Testing facilities Academic Institutes and Research Laboratories, Bio and health informatics companies), By Therapeutic Area(Cardiology, Antiviral, Psychiatry, Oncology, Neurology), Industry Trends, Estimation & Forecast, 2017 - 2025

July 2018

 Pages: 186

 ERC 9603

 Formats*:  

Personalized Medicine Market is expected to grow with a CAGR of xx% during the forecast period of 2018 to 2025.

Personalized medication is an advanced version of the conventional approaches for the treatment of diseases on an individual level. It is a process of diagnosing and preventing a disease by providing treatment to a patient using the information regarding his/her genetic structure, proteins, and the external environment. It’s a methodology which is based upon the analysis of unique risks associated to a specific person regarding specific diseases. The major advantage of this medicine therapy is that, it incorporates the usage of highly precise equipment and tools, coupled with specialized doctors who determine the treatment on the basis of patient’s molecular profile after the analysis of harmful side effects. This saves the patient from unnecessary delay in the treatment and extra cost which is caused by the conventional trial and error approach. A continuous rise in the number of patients suffering from critical diseases, especially in the developed countries, are getting more oriented towards personalized treatments. This is acting as a major driving factor for the growth of the personalized medicine market. Moreover, persistent research and development activities in the field of medicine, coupled with the rising awareness regarding advanced treatments of chronic diseases such as Cancer and Diabetes will boost the market pace in the near future. Apart from this, favorable initiatives taken by the government to introduce personalized medication therapy, in various countries can emerge out as a major opportunity for the expansion of the very market.

There are various funded programs supported by the European Union for the development of biotechnology research and personalized medicine. For example, the EU has already sanctioned a fund of more than 3 billion euros for the personalized medication research. This fund has come from the research framework programs FP7 and Horizon 2020. However, high cost of such treatment procedures and lack of awareness regarding personalized medicine in both developing and under- developed countries can act as a hampering agent for the market.

The report provides detailed qualitative and quantitative analysis of the Personalized Medicine Market. Market size and forecast in terms of value and volume has been provided for the period - (2017 - 2025), for the segments namely application, end-user and therapeutic area in each of the major regions.

Personalized Medicine Market Player Analysis

The report presents detailed analysis of major players operating in Personalized Medicine Market. Few of them include Abbott Laboratories, ASURAGEN, INC., bioMerieux SA, Bristol-Myers Squibb, CETICS Healthcare Technologies GmbH, GlaxoSmithKline, IBM Corporation, Illumina, Inc., Intomics A/S, JOHNSON & JOHNSON, Laboratory Corporation of America, F. Hoffmann-La Roche AG, GE Healthcare, Gilead Sciences, Inc., Merck KGaA, Novartis AG, Pfizer, Inc., Quest Diagnostics, Randox Laboratories, SANOFI, Almac Group, Amgen, Inc., Astellas Pharma, Inc., AstraZeneca PLC, Teva Pharmaceuticals Limited and Thermo Fisher Scientific. A detailed coverage on these market players with information on their revenue from Personalized Medicine business, market share, gross margin and their growth strategies have been provided in the report.

Market Segmentation

Personalized Medicine market is segmented on the basis of application, end-user, therapeutic area and geography. On the basis of application, the market is categorized as Health Informatics, Clinical Research, Companion Diagnostics and Biomarker identification. By end-user, the market is segmented into hospitals, contract research organizations, molecular diagnostic laboratories and testing facilities, academic institutes and research laboratories, bio and health informatics companies and others. On the basis of therapeutic area, the market is classified into cardiology, antiviral, psychiatry and oncology, neurology and others. Geographical coverage has been provided for each of the major regions including North America, Europe, Asia-Pacific, South America and Rest of the World.

Personalized Medicine Market Segmentation

By Application
• Health Informatics
• Clinical Research
• Companion Diagnostics
• Biomarker identification

By End-user
• Hospitals
• Contract Research Organizations
• Molecular Diagnostic Laboratories and Testing facilities
• Academic Institutes and Research Laboratories
• Bio and health informatics companies
• Others

By Therapeutic area
• Cardiology
• Antiviral
• Psychiatry
• Oncology
• Neurology
• Others

By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o U.K.
o France
o Germany
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o China
o Japan
o India
o Korea
o Rest of APAC
• South America
o Brazil
o Rest of South America
• Rest of the World
o Middle East
o Africa

Personalized Medicine Market Key Players

• Abbott Laboratories
• ASURAGEN, INC.
• bioMerieux SA
• Bristol-Myers Squibb
• CETICS Healthcare Technologies GmbH
• GlaxoSmithKline
• IBM Corporation
• Illumina, Inc.
• Intomics A/S
• JOHNSON & JOHNSON
• Laboratory Corporation of America
• F. Hoffmann-La Roche AG
• GE Healthcare
• Gilead Sciences, Inc.
• Merck KGaA
• Novartis AG
• Pfizer, Inc.
• Quest Diagnostics
• Randox Laboratories
• SANOFI
• Almac Group
• Amgen, Inc.
• Astellas Pharma, Inc.
• AstraZeneca PLC
• Teva Pharmaceuticals Limited
• Thermo Fisher Scientific

Please fill in the form below to Request for Customized Report
  
Your personal details are safe and secured with us. Privacy Policy

To request sample copy of this report, please complete the form below verified and secure

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

  
Your personal details are safe and secured with us. Privacy Policy

    What Information does this report contain?

    • What was the market size of the Personalized Medicine Market in 2017 and the expected market size by 2025, along with the growth rate?
    • An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
    • Which are the largest revenue generating products, services or regions and their comparative growth rate?
    • Which technology is in trend and how would it evolve during the forecast period (2017 - 2025)?
    • Which are the leading companies in the Personalized Medicine Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

Purchase Options





Offers & Discounts

  • Chapter purchase
  • Historical market data
  • Country level data breakdown
  • Free customization*
  • Discounts for first time
  • Special pricing for
              non-business entities

Customize

  • We offer 20% free customization on every purchase.

Get in touch!

  +91-844-601-6060


  help@esticastresearch.com